User:Mr. Ibrahem/Darolutamide

Darolutamide, sold under the brand name Nubeqa, is a medication used to treat prostate cancer. Specifically it is used for non-metastatic castration-resistant prostate cancer (nmCRPC) together with surgical or medical castration. The medication is taken by mouth twice per day with food.

Common side effects include tiredness, pain in the arms and legs, and rash. Other side effects may include infertility and low white blood cells. Use during pregnancy by either the male or female may harm the baby. It is a nonsteroidal antiandrogen (NSAA) and works by preventing androgens from binding to the androgen receptor.

Darolutamide was patented in 2011. It was approved for medical use in the United States in 2019 and Europe and Australia in 2020. In the United Kingdom 4 weeks of medication costs the NHS about £4,000 as of 2021. This amount in the United States is about 11,000 USD.